Avinger to participate in hc wainwright conference

Redwood city, ca / accesswire / january 6, 2021 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for the diagnosis and treatment of peripheral artery disease (pad), today announced that its executive team will participate in the h.c. wainwright bioconnect 2021 conference taking place virtually january 11-14, 2021.
AVGR Ratings Summary
AVGR Quant Ranking